Pharma buyout News
Most Popular Pharma buyout Story
Novartis pledges $39B for Alcon
In a bid to diversify its business away from traditional pharma, Novartis has bought a 25 percent stake in Alcon and is eyeing the purchase of another 52 percent in 2010. The Swiss drugmaker paid Read more...
Latest Headlines
- July 11, 2011
- April 13, 2011
- April 8, 2010
- April 7, 2010
- March 30, 2010
- March 4, 2010
- March 3, 2010
- March 2, 2010
- February 18, 2010
- February 11, 2010
- February 3, 2010
- February 1, 2010
- January 20, 2010
- January 15, 2010
- January 12, 2010
- January 5, 2010
- November 30, 2009
- September 28, 2009
- May 5, 2009
- April 24, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
